Manufacture of medicines and other pharmaceutical products (PKD 21.20.Z)2007
Industry statistics (2025)
Number of companies
Companies
5,093
Companies (primary PKD)
449
Companies with financials
257
Business turnover
Legal structure
Legal formShare of companiesNumber of companies
- Sp. z o.o.71.9%323
- S.A.7.8%35
- Sp. j.6.9%31
- JDG6.7%30
- Sp. k.2.0%9
- P.S.A.1.8%8
- Cooperative1.3%6
- Other0.9%4
- Foundation0.7%3
Financial results
Median revenue
Ranking
Median revenue compared with other PKD codes.
Top companies by revenue
| # | Company | Legal form | Revenue | Net profit |
|---|---|---|---|---|
| 1 | S.A. | USD 1.25bn | USD 236.49m | |
| 2 | S.A. | USD 615.32m | USD 16.99m | |
| 3 | S.A. | USD 539.49m | USD 53.86m | |
| 4 | sp. z o.o. | USD 527.04m | USD 77.39m | |
| 5 | sp. z o.o. | USD 300.66m | USD 59.18m | |
| 6 | sp. z o.o. | USD 245.99m | USD 33.23m | |
| 7 | S.A. | USD 159.45m | USD 6.68m | |
| 8 | sp. z o.o. | USD 142.78m | USD 34.11m | |
| 9 | S.A. | USD 119.08m | USD 4.98m | |
| 10 | sp. z o.o. | USD 112.36m | USD 2.95m |
Fastest-growing companies
| # | Company | Legal form | Revenue | Y/Y growth |
|---|---|---|---|---|
| 1 | sp. z o.o. | USD 47.06m | +92.4% y/y | |
| 2 | sp. z o.o. | USD 3.81m | +83.9% y/y | |
| 3 | sp. z o.o. | USD 21.37m | +57.8% y/y | |
| 4 | sp. z o.o. | USD 4.24m | +54.9% y/y | |
| 5 | sp. z o.o. | USD 5.96m | +40.1% y/y | |
| 6 | sp. z o.o. | USD 20.12m | +37.3% y/y | |
| 7 | S.A. | USD 72.84m | +37.2% y/y | |
| 8 | sp. z o.o. | USD 4.39m | +32.0% y/y | |
| 9 | sp. z o.o. | USD 2.27m | +28.3% y/y | |
| 10 | sp. z o.o. | USD 24.58m | +26.2% y/y |
Stock market
No companies from this industry are listed.
Related PKD codes in division 21
FAQ
The primary industry for 449 companies is manufacture of medicines and other pharmaceutical products. 257 entities have filed financial statements.
In 2024, 18 new companies with PKD 21.20.Z were registered. In all of 2023, there were 14 such companies.
In 2024, 2 companies with PKD 21.20.Z were deregistered. In all of 2023, there were 2 such companies.
In 2025, the median revenue for PKD 21.20.Z was USD 1.48m and the mean revenue was USD 34.30m, based on 186 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
Yes, in 2025, the median net profit was USD 34.84k, an improvement on 2024 (USD 13.02k). Among all 626 industries in Poland, PKD 21.20.Z ranks 173rd, putting it in the top 28%.
The most common legal form for PKD 21.20.Z is sp. z o.o., used by 323 companies in this industry (71.9% of the total). In second place is S.A. (35 companies, 7.8%), and in third place – sp. j. (31 companies, 6.9%).











